Nothing Special   »   [go: up one dir, main page]

NO890724D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.

Info

Publication number
NO890724D0
NO890724D0 NO890724A NO890724A NO890724D0 NO 890724 D0 NO890724 D0 NO 890724D0 NO 890724 A NO890724 A NO 890724A NO 890724 A NO890724 A NO 890724A NO 890724 D0 NO890724 D0 NO 890724D0
Authority
NO
Norway
Prior art keywords
tetraazaacenapylene
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO890724A
Other languages
English (en)
Other versions
NO169589C (no
NO890724L (no
NO169589B (no
Inventor
Joseph William Epstein
Jeremy Ian Levin
Shin Shyong Tseng
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO890724D0 publication Critical patent/NO890724D0/no
Publication of NO890724L publication Critical patent/NO890724L/no
Publication of NO169589B publication Critical patent/NO169589B/no
Publication of NO169589C publication Critical patent/NO169589C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO890724A 1988-02-22 1989-02-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater NO169589C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15844888A 1988-02-22 1988-02-22

Publications (4)

Publication Number Publication Date
NO890724D0 true NO890724D0 (no) 1989-02-21
NO890724L NO890724L (no) 1989-08-23
NO169589B NO169589B (no) 1992-04-06
NO169589C NO169589C (no) 1992-07-15

Family

ID=22568168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890724A NO169589C (no) 1988-02-22 1989-02-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater

Country Status (23)

Country Link
EP (1) EP0329940B1 (no)
JP (1) JP2641556B2 (no)
KR (1) KR970009226B1 (no)
AR (1) AR247211A1 (no)
AT (1) ATE99686T1 (no)
AU (1) AU611769B2 (no)
CA (1) CA1329594C (no)
CZ (1) CZ284273B6 (no)
DD (1) DD283624A5 (no)
DE (1) DE68911951T2 (no)
DK (1) DK172397B1 (no)
ES (1) ES2061739T3 (no)
FI (1) FI89922C (no)
HU (1) HU203554B (no)
IE (1) IE64147B1 (no)
IL (1) IL88974A (no)
NO (1) NO169589C (no)
NZ (1) NZ228009A (no)
PH (1) PH26358A (no)
PL (1) PL158865B1 (no)
PT (1) PT89766B (no)
SK (1) SK279319B6 (no)
ZA (1) ZA891310B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013737A (en) * 1988-02-22 1991-05-07 American Cyanamid Company 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
EP0562236A1 (en) * 1992-03-26 1993-09-29 American Cyanamid Company Process for the synthesis of 5-[(substituted)-amino]-8-[phenyl or substiutued-phenyl]-3H, 6H-1, 4, 5A, 8A-tetraazaacephthylen-3-ones
EP0957918A1 (en) * 1996-12-19 1999-11-24 American Cyanamid Company Method of treating or inhibiting neutropenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4576943A (en) * 1984-10-09 1986-03-18 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines
EP0264773A1 (en) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines

Also Published As

Publication number Publication date
CZ284273B6 (cs) 1998-10-14
HU203554B (en) 1991-08-28
NZ228009A (en) 1991-09-25
ES2061739T3 (es) 1994-12-16
KR970009226B1 (en) 1997-06-09
KR890013022A (ko) 1989-09-20
IL88974A (en) 1993-03-15
ZA891310B (en) 1989-11-29
NO169589C (no) 1992-07-15
NO890724L (no) 1989-08-23
PL158865B1 (pl) 1992-10-30
SK105589A3 (en) 1998-09-09
IL88974A0 (en) 1989-08-15
PT89766A (pt) 1989-10-04
PT89766B (pt) 1994-03-31
PH26358A (en) 1992-04-29
FI89922C (fi) 1993-12-10
CZ105589A3 (cs) 1998-07-15
JP2641556B2 (ja) 1997-08-13
EP0329940B1 (en) 1994-01-05
IE64147B1 (en) 1995-07-12
JPH01249774A (ja) 1989-10-05
EP0329940A1 (en) 1989-08-30
DE68911951T2 (de) 1994-06-01
FI890826A (fi) 1989-08-23
HUT51626A (en) 1990-05-28
PL277837A1 (en) 1989-11-13
AR247211A1 (es) 1994-11-30
ATE99686T1 (de) 1994-01-15
DD283624A5 (de) 1990-10-17
DK79589A (da) 1989-08-23
FI89922B (fi) 1993-08-31
FI890826A0 (fi) 1989-02-21
CA1329594C (en) 1994-05-17
AU3017289A (en) 1989-08-24
NO169589B (no) 1992-04-06
DE68911951D1 (de) 1994-02-17
DK79589D0 (da) 1989-02-21
AU611769B2 (en) 1991-06-20
DK172397B1 (da) 1998-05-18
SK279319B6 (sk) 1998-09-09
IE890543L (en) 1989-08-22

Similar Documents

Publication Publication Date Title
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO893909L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO895220D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO890607L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002